It has been months since public health authorities registered another fatality related to the tragic fungal meningitis outbreak traced to a contaminated compounding pharmacy last fall. Two people died in the last month alone, bringing the total national fatality count to 51.
The U.S. Centers for Disease Control also announced that 16 more Americans are battling meningitis or related infections since this time last month. That puts the current number of victims at 730. A CDC official warned that the incubation period for this fungal meningitis outbreak is still unknown-he said that the CDC expects that more patients will continue to develop symptoms for at least six more months.
This outbreak occurred because a compounding pharmacy failed to follow proper sterilization procedures. As a result, the company allowed its supposedly sterile products to become contaminated with a common mold that is usually found in soil. The case has become an infamous example of product liability concerns-manufacturers like these pharmacies have a big responsibility to make sure that their facilities produce safe medical products.
When companies sell defective drugs, injured consumers are entitled to hold them accountable for dangerous mistakes.
Source: Boston Herald, "Compounding pharmacy death toll continues to rise," Laurel J. Sweet, Mar. 26, 2013